Publications (Prior to 2010)
Tregs control the development of symptomatic West Nile virus infection in humans and mice.
Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ.J Clin Invest. 2009 Nov;119(11):3266-77. doi: 10.1172/JCI39387. Epub 2009 Oct 12.PMID: 19855131
Milush JM, Long BR, Snyder-Cappione JE, Cappione AJ 3rd, York VA, Ndhlovu LC, Lanier LL, Michaëlsson J, Nixon DF.Blood. 2009 Nov 26;114(23):4823-31. doi: 10.1182/blood-2009-04-216374. Epub 2009 Oct 5.PMID: 19805616
Ndhlovu LC, Snyder-Cappione JE, Carvalho KI, Leal FE, Loo CP, Bruno FR, Jha AR, Devita D, Hasenkrug AM, Barbosa HM, Segurado AC, Nixon DF, Murphy EL, Kallas EG.Clin Exp Immunol. 2009 Dec;158(3):294-9. doi: 10.1111/j.1365-2249.2009.04019.x. Epub 2009 Sep 2.PMID: 19778295
A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.
Melo KM, Carvalho KI, Bruno FR, Ndhlovu LC, Ballan WM, Nixon DF, Kallas EG, Costa-Carvalho BT.PLoS One. 2009 Jul 29;4(7):e6269. doi: 10.1371/journal.pone.0006269.PMID: 19649263
Torheim EA, Ndhlovu LC, Pettersen FO, Larsen TL, Jha AR, Torgersen KM, Kvale D, Nixon DF, Taskén K, Aandahl EM.Eur J Immunol. 2009 May;39(5):1280-7. doi: 10.1002/eji.200839002.PMID: 19384871
Barbour JD, Ndhlovu LC, Xuan Tan Q, Ho T, Epling L, Bredt BM, Levy JA, Hecht FM, Sinclair E.PLoS One. 2009;4(2):e4408. doi: 10.1371/journal.pone.0004408. Epub 2009 Feb 9.PMID: 19198651
Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, Wong JC, Satkunarajah M, Schweneker M, Chapman JM, Gyenes G, Vali B, Hyrcza MD, Yue FY, Kovacs C, Sassi A, Loutfy M, Halpenny R, Persad D, Spotts G, Hecht FM, Chun TW, McCune JM, Kaul R, Rini JM, Nixon DF, Ostrowski MA.J Exp Med. 2008 Nov 24;205(12):2763-79. doi: 10.1084/jem.20081398. Epub 2008 Nov 10.PMID: 19001139
Schenk K, Ndhlovu L, Tembo S, Nsune A, Nkhata C, Walusiku B, Watts C.AIDS Care. 2008 Sep;20(8):894-903. doi: 10.1080/09540120701767232.PMID: 18777218
Chen S, Ndhlovu LC, Takahashi T, Takeda K, Ikarashi Y, Kikuchi T, Murata K, Pandolfi PP, Riccardi C, Ono M, Sugamura K, Ishii N.Eur J Immunol. 2008 Aug;38(8):2229-40. doi: 10.1002/eji.200838167.PMID: 18624295
Ndhlovu LC, Chapman JM, Jha AR, Snyder-Cappione JE, Pagán M, Leal FE, Boland BS, Norris PJ, Rosenberg MG, Nixon DF.AIDS. 2008 May 11;22(8):990-2. doi: 10.1097/QAD.0b013e3282ff884e.PMID: 18453860
Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, Barbour JD.J Virol. 2008 May;82(10):4785-92. doi: 10.1128/JVI.02449-07. Epub 2008 Feb 27.PMID: 18305035
Malope BI, MacPhail P, Mbisa G, MacPhail C, Stein L, Ratshikhopha EM, Ndhlovu L, Sitas F, Whitby D.AIDS. 2008 Feb 19;22(4):519-26. doi: 10.1097/QAD.0b013e3282f46582.PMID: 18301065
T cell responses to human endogenous retroviruses in HIV-1 infection.
Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, Chapman JM, Erickson AL, Agrawal A, Spotts G, Hecht FM, Rakoff-Nahoum S, Lenz J, Ostrowski MA, Nixon DF.PLoS Pathog. 2007 Nov;3(11):e165. doi: 10.1371/journal.ppat.0030165.PMID: 17997601
Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM.J Leukoc Biol. 2008 Feb;83(2):254-62. doi: 10.1189/jlb.0507281. Epub 2007 Nov 2.PMID: 17982112
Kim JC, Watts CH, Hargreaves JR, Ndhlovu LX, Phetla G, Morison LA, Busza J, Porter JD, Pronyk P.Am J Public Health. 2007 Oct;97(10):1794-802. doi: 10.2105/AJPH.2006.095521. Epub 2007 Aug 29.PMID: 17761566
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.
Chen S, Ishii N, Ine S, Ikeda S, Fujimura T, Ndhlovu LC, Soroosh P, Tada K, Harigae H, Kameoka J, Kasai N, Sasaki T, Sugamura K.Int Immunol. 2006 Feb;18(2):269-77. doi: 10.1093/intimm/dxh366. Epub 2005 Dec 16.PMID: 16361311
Ndhlovu LC, Takeda I, Sugamura K, Ishii N.Crit Rev Immunol. 2004;24(4):251-66. doi: 10.1615/critrevimmunol.v24.i4.30.PMID: 15588225
Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.
Takeda I, Ine S, Killeen N, Ndhlovu LC, Murata K, Satomi S, Sugamura K, Ishii N.J Immunol. 2004 Mar 15;172(6):3580-9. doi: 10.4049/jimmunol.172.6.3580.PMID: 15004159
Williams BG, Taljaard D, Campbell CM, Gouws E, Ndhlovu L, Van Dam J, Caraël M, Auvert B.AIDS. 2003 Sep 26;17(14):2099-107. doi: 10.1097/00002030-200309260-00011.PMID: 14502013
OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.
Ishii N, Ndhlovu LC, Murata K, Sato T, Kamanaka M, Sugamura K.Eur J Immunol. 2003 Sep;33(9):2372-81. doi: 10.1002/eji.200324031.PMID: 12938213
Sato T, Ishii N, Murata K, Kikuchi K, Nakagawa S, Ndhlovu LC, Sugamura K.Eur J Immunol. 2002 Nov;32(11):3326-35. doi: 10.1002/1521-4141(200211)32:11<3326::AID-IMMU3326>3.0.CO;2-9.PMID: 12555678
Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
Murata K, Nose M, Ndhlovu LC, Sato T, Sugamura K, Ishii N.J Immunol. 2002 Oct 15;169(8):4628-36. doi: 10.4049/jimmunol.169.8.4628.PMID: 12370402
Ndhlovu LC, Ishii N, Murata K, Sato T, Sugamura K.J Immunol. 2001 Sep 1;167(5):2991-9. doi: 10.4049/jimmunol.167.5.2991.PMID: 11509650
Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand.
Murata K, Ishii N, Takano H, Miura S, Ndhlovu LC, Nose M, Noda T, Sugamura K.J Exp Med. 2000 Jan 17;191(2):365-74. doi: 10.1084/jem.191.2.365.PMID: 10637280
Miller RA, Stein K, Miller K, Ndhlovu L, Maggwa N, Sanogo D, Kondo E.Afr J Fertil Sexual Reprod Heal. 1996 Dec;1(2):92-100.PMID: 12321203
A comparison of the 1995 and 1989 Kenya Situation Analysis Study findings.
Miller R, Miller K, Ndhlovu L, Solo J, Achola O.Afr J Fertil Sexual Reprod Heal. 1996 Dec;1(2):162-8.PMID: 12321199
The Situation Analysis Study of the family planning program in Kenya.
Miller RA, Ndhlovu L, Gachara MM, Fisher AA.Stud Fam Plann. 1991 May-Jun;22(3):131-43.PMID: 1949097
Characteristics of new contraceptive acceptors in Zimbabwe.
Dow T, Chombo J, Ndhlovu L, Shumba P, Dhlodhlo B.Stud Fam Plann. 1986 Mar-Apr;17(2):107-13.PMID: 3705131